药物-二氧化硅共组装颗粒提升根管封闭剂抗菌性能
本研究将新型高载药抗菌药物-二氧化硅共组装颗粒(DSPs)以1%和2%质量分数加入环氧树脂类封闭剂AH Plus或硅酸钙类封闭剂EndoSequence Bioceramic Sealer,评估其抗粪肠球菌活性、OCT释放及流动性。结果显示DSPs增强BC封闭剂30天抗菌活性,对AH无效,除AH+2%DSPs外流动性均符合ISO 6876标准。
要点
- DSPs可增强BC封闭剂对粪肠球菌的30天抗菌活性。
- DSPs未增强AH封闭剂的抗菌活性,7天后即无抗菌作用。
- DSPs降低封闭剂流动性,AH+2%DSPs超出ISO 6876限值。
核心结论
- DSPs增强BC封闭剂的抗菌性能但不增强AH封闭剂,且材料流动性仍符合ISO 6876标准。
- 根据封闭剂类型,DSPs可能增强根管治疗的抗菌效果并潜在改善治疗结果。
研究设计与样本
- 体外研究,合成DSPs并以1%和2%质量分数加载到AH Plus或EndoSequence Bioceramic Sealer中。
- 采用液相色谱测定OCT释放,用直接接触和膜限制试验评估对浮游及生物膜粪肠球菌的抗菌活性,按ISO6876:2012测试流动性。
主要发现
- BC+1%或2%DSPs在30天实验期间第2天后OCT释放高于最低抑菌浓度。
- AH+1%或2%DSPs在整个30天实验期间OCT释放显著低于对粪肠球菌的最低抑菌浓度(4 μg/mL)。
- 所有材料(含或不含DSPs)初始均能杀死浮游细菌,AH±1%或2%DSPs在7天后无抗菌活性,BC+1%或2%DSPs维持抗菌活性30天。
- 改性与未改性封闭剂接触24小时后均完全抑制粪肠球菌生物膜生长。
- DSPs降低AH和BC封闭剂流动性,AH的降低与DSPs添加量成比例;除AH+2%DSPs外所有封闭剂流动性在ISO 6876可接受限值内。
关键数值与推荐
- OCT对粪肠球菌的最低抑菌浓度为4 μg/mL。
- BC+1%或2%DSPs在30天实验期间第2天后OCT释放高于最低抑菌浓度。
- AH+1%或2%DSPs在整个30天实验期间OCT释放显著低于最低抑菌浓度。
- 所有改性与未改性封闭剂接触24小时后完全抑制粪肠球菌生物膜生长。
- 除AH+2%DSPs外,所有改性与未改性封闭剂流动性符合ISO 6876测试可接受限值。
临床怎么用
- 对于硅酸钙类封闭剂BC,可考虑添加1%或2%DSPs以增强长期抗菌活性。
- 对于环氧树脂类封闭剂AH,添加DSPs未显示抗菌增益,且2%添加量可能影响流动性合规性。
- 临床应用前需权衡DSPs对封闭剂流动性的影响,确保符合ISO 6876标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The purpose of this study was to assess the antimicrobial activity and flow of root canal sealers after incorporating novel highly loaded antimicrobial drug-silica coassembled particles (DSPs). METHODS: DSPs were synthesized through coassembly of silica and octenidine dihydrochloride (OCT) antimicrobial surfactant. DSPs were loaded (1% and 2% wt) into epoxy resin sealer (AH Plus [AH]; Dentsply DeTrey GmbH, Konstanz, Germany) or calcium silicate-based sealer (EndoSequence Bioceramic Sealer (BC); Brasseler, Savannah, GA). OCT release from DSP-modified sealers was determined using liquid chromatography. Antimicrobial activity of sealers against planktonic or biofilm form Enterococcus faecalis was assessed using direct contact and membrane restricted tests. Sealer flow was tested according to ISO6876:2012. RESULTS: OCT release from BC + 1% or 2% DSPs was above the minimum inhibitory concentration following 2 days throughout the 30-day experiment, whereas OCT release from AH + 1% or 2% DSP was significantly below the minimum inhibitory concentration against E. faecalis (4 μg/mL) over the whole 30-day experimental period. All materials (with or without DSPs) killed planktonic bacteria initially. AH ± 1% or 2% DSPs had no antimicrobial activity after 7 days. BC + 1% or 2% DSPs maintained antibacterial activity over the 30-day period. Both modified and unmodified sealers completely inhibited the growth of E. faecalis biofilms after 24 hours of contact. DSPs decreased the flow of AH and BC sealers; for AH, the reduction was proportional to the amount of DSPs added. All modified and unmodified sealers, except for AH + 2% DSPs, were within the acceptable limits of ISO 6876 flow tests. CONCLUSIONS: DSPs enhanced the antimicrobial performance of BC but not AH, whereas the material's flow remained compliant with ISO 6876 standards. Depending on the sealer, DSPs may enhance antimicrobial efficacy in root canal treatment and potentially improve treatment outcome.
引用
- Marashdeh M, Stewart C, Kishen A, et al. Drug-Silica Coassembled Particles Improve Antimicrobial Properties of Endodontic Sealers. J Endod. 2021. PMID: 33582178. doi:10.1016/j.joen.2021.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。